Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320918 · ClinicalTrials.gov registry record
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00320918 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 10 participants.
The verdict
NCT00320918 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-11 |
| Est. Completion | 2006-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320918
The ClinicalTrials.gov registry entry for NCT00320918 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00320918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320918 about?
NCT00320918 is a clinical study titled "Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib". Chart Review on Patients with unresectable/metastatic cholangiocarcinoma treated in the UNM Cancer Center with a combination of irinotecan, capecitabine and celecoxib.
What is the current status of trial NCT00320918?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2005-11. Estimated completion is 2006-10.
Who is sponsoring clinical trial NCT00320918?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.